Brain neuropeptide Y (NPY) in stress and alcohol dependence.
- Authors
- Heilig, Markus; Thorsell, Annika
- Year
- 2002
- Journal
- Reviews in the neurosciences
- PMID
- 12013027
- DOI
- 10.1515/revneuro.2002.13.1.85
Neuropeptide Y (NPY), the prototypical member of the NPY-like peptide family, antagonizes behavioral consequences of stress through actions within the brain. This was initially indicated by microinjection studies with NPY receptor ligands, suggesting that NPY Y1 receptors mediate the anti-stress effects of NPY. Behavioral anti-stress actions of NPY are note-worthy in that 1) their magnitude surpasses that of other endogenous compounds; 2) they are produced across a wide range of animal models, normally thought to reflect different aspects of emotionality. These findings suggest that NPY acts with a high potency on a common core mechanism of emotionality and behavioral stress responses. This hypothesis is supported by behavioral studies in genetically modified animals. Increased emotionality, as well as increased alcohol intake, has been reported in mice with a homologous recombination knockout of the preproNPY gene. More detailed studies have been made possible by a transgenic rat system, in which NPY is selectively overexpressed within the hippocampus. These subjects display no overt phenotype under baseline conditions and have a normal endocrine stress response, but lack behavioral responses to stress. These findings point to the potential of the NPY system for developing novel pharmacological treatments of stress-related disorders, including anxiety and depression. Recent data additionally point to a role of NPY in the regulation of alcohol intake, and alcohol dependence emerges as a novel potential indication for compounds targeting the NPY system.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Revisited case for intranasal neuropeptide Y based therapeutics: From preclinical to clinical. | Sabban EL et al. | β | 2026 | β |
| Neuropeptide Y gene variants and Agreeableness: interaction effect with the birth cohort and the serotonin transporter promoter polymorphism. | Kiive E et al. | β | 2024 | β |
| NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer. | Bhat R et al. | β | 2022 | β |
| Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. | Fischler PV et al. | β | 2022 | β |
| Elevated lead levels in relation to low serum neuropeptide Y and adverse behavioral effects in preschool children with e-waste exposure. | Zeng X et al. | β | 2021 | β |
| Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation? | Borruto AM et al. | β | 2021 | β |
| Loneliness: An Immunometabolic Syndrome. | Pourriyahi H et al. | β | 2021 | β |
| Long term effects of stress on hippocampal function: Emphasis on early life stress paradigms and potential involvement of neuropeptide Y. | AlviΓ±a K et al. | β | 2021 | β |
| Electro-Acupuncture Attenuates Chronic Stress Responses <i>via</i> Up-Regulated Central NPY and GABA <sub><i>A</i></sub> Receptors in Rats. | Yang Y et al. | β | 2020 | β |
| In utero Ξ9-tetrahydrocannabinol exposure confers vulnerability towards cognitive impairments and alcohol drinking in the adolescent offspring: Is there a role for neuropeptide Y? | Brancato A et al. | β | 2020 | β |
| Neuropeptide Y plasma levels and suicidal behavior in combat veterans. | Sher L et al. | β | 2020 | β |
| Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders. | Nahvi RJ et al. | β | 2020 | β |
| Neuropeptide Y and representation of salience in human nucleus accumbens. | Warthen KG et al. | β | 2019 | β |
| Central Neuropeptide Y Plays an Important Role in Mediating the Adaptation Mechanism Against Chronic Stress in Male Rats. | Yang Y et al. | β | 2018 | β |
| Sexually Dimorphic Patterns of Cell Proliferation in the Brain Are Linked to Seasonal Life-History Transitions in Red-Sided Garter Snakes. | Lutterschmidt DI et al. | β | 2018 | β |
| Adolescent Alcohol Exposure-Induced Changes in Alpha-Melanocyte Stimulating Hormone and Neuropeptide Y Pathways via Histone Acetylation in the Brain During Adulthood. | Kokare DM et al. | β | 2017 | β |
| Arginine Vasotocin and Neuropeptide Y Vary with Seasonal Life-History Transitions in Garter Snakes. | Lucas AR et al. | β | 2017 | β |
| Circuit and synaptic mechanisms of repeated stress: Perspectives from differing contexts, duration, and development. | Bath KG et al. | β | 2017 | β |
| High-Throughput Screening Assay Datasets from the PubChem Database. | Butkiewicz M et al. | β | 2017 | β |
| Neuroclinical Framework for the Role of Stress in Addiction. | Kwako LE et al. | β | 2017 | β |
| A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction. | Bell RL et al. | β | 2016 | β |
| Neurobiology of addiction: a neurocircuitry analysis. | Koob GF et al. | β | 2016 | β |
| Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight. | Qiu B et al. | β | 2016 | β |
| Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder. | Sabban EL et al. | β | 2016 | β |
| Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors. | Ledri LN et al. | β | 2016 | β |
| Endogenous opioids: opposing stress with a cost. | Valentino RJ et al. | β | 2015 | β |
| Endogenous Opioids: The Downside of Opposing Stress. | Valentino RJ et al. | β | 2015 | β |
| Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats. | Bari A et al. | β | 2015 | β |
| Neuropeptide regulation of signaling and behavior in the BNST. | Kash TL et al. | β | 2015 | β |
| Sex or candy? Neuroendocrine regulation of the seasonal transition from courtship to feeding behavior in male red-sided garter snakes (Thamnophis sirtalis parietalis). | Lutterschmidt DI et al. | β | 2014 | β |
| Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. | Veyrat-Durebex C et al. | β | 2013 | β |
| Gene environment interaction studies in depression and suicidal behavior: An update. | Mandelli L et al. | β | 2013 | β |
| Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. | Everds NE et al. | β | 2013 | β |
| Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats. | Hsieh YS et al. | β | 2013 | β |
| Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats. | Kotagale NR et al. | β | 2013 | β |
| Acupuncture at ST36 prevents chronic stress-induced increases in neuropeptide Y in rat. | Eshkevari L et al. | β | 2012 | β |
| Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity. | Bell RL et al. | β | 2012 | β |
| Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems. | Bell RL et al. | β | 2012 | β |
| Peptide therapeutics for CNS indications. | McGonigle P | β | 2012 | β |
| The role of neuropeptide Y in energy homeostasis. | Chambers AP et al. | β | 2012 | β |
| Treatment of alcohol dependence with drug antagonists of the stress response. | Higley AE et al. | β | 2012 | β |
| Developmental programming of energy balance and its hypothalamic regulation. | Remmers F et al. | β | 2011 | β |
| Identification of a Smad4/YY1-recognized and BMP2-responsive transcriptional regulatory module in the promoter of mouse GABA transporter subtype I (Gat1) gene. | Yao M et al. | β | 2010 | β |
| Understanding and treating alcohol craving and dependence: recent pharmacological and neuroendocrinological findings. | Leggio L | β | 2009 | β |
| Analysis of single nucleotide polymorphisms and haplotypes in the neuropeptide Y gene: no evidence for association with alcoholism in a German population sample. | Zill P et al. | β | 2008 | β |
| A role for brain stress systems in addiction. | Koob GF | β | 2008 | β |
| Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. | Thorsell A | β | 2008 | β |
| Molecular genetics of the stress-responsive adrenocortical axis. | Redei EE | β | 2008 | β |
| Neurobiology of addiction. An integrative review. | Goodman A | β | 2008 | β |
| Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. | Wetherill L et al. | β | 2008 | β |
| Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. | Jerlhag E et al. | β | 2007 | β |
| Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus. | Gaszner B et al. | β | 2007 | β |
| Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background. | Badia-Elder NE et al. | β | 2007 | β |
| Neuropeptide Y (NPY) in alcohol intake and dependence. | Thorsell A | β | 2007 | β |
| Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. | Ciccocioppo R et al. | β | 2006 | β |
| Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. | Jerlhag E et al. | β | 2006 | β |
| Sex- and clock-controlled expression of the neuropeptide F gene in Drosophila. | Lee G et al. | β | 2006 | β |
| The alcohol-preferring P rat and animal models of excessive alcohol drinking. | Bell RL et al. | β | 2006 | β |
| The effects of social isolation on neuropeptide Y levels, exploratory and anxiety-related behaviors in rats. | Thorsell A et al. | β | 2006 | β |
| AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. | Gardiner JV et al. | β | 2005 | β |
| A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. | Mottagui-Tabar S et al. | β | 2005 | β |
| Effect of polymorphism on expression of the neuropeptide Y gene in inbred alcohol-preferring and -nonpreferring rats. | Spence JP et al. | β | 2005 | β |
| Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. | Thorsell A et al. | β | 2005 | β |
| Increased fasting plasma ghrelin levels during alcohol abstinence. | Kim DJ et al. | β | 2005 | β |
| No significant effect of acute moderate alcohol intake on leptin levels in healthy male volunteers. | Dammann G et al. | β | 2005 | β |
| Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. | Rimondini R et al. | β | 2005 | β |
| The impact of emotional stress early in life on adult voluntary ethanol intake-results of maternal separation in rats. | Roman E et al. | β | 2005 | β |
| A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. | Arlinde C et al. | β | 2004 | β |
| Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. | Heilig M et al. | β | 2004 | β |
| Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence. | Heilig M et al. | β | 2004 | β |
| Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability. | Palomo T et al. | β | 2004 | β |
| Genomic regions controlling corticosterone levels in rats. | Potenza MN et al. | β | 2004 | β |
| Neuropeptides: implications for alcoholism. | Cowen MS et al. | β | 2004 | β |
| Stress and alcohol drinking. | Sillaber I et al. | β | 2004 | β |
| Trends in the development of new antidepressants. Is there a light at the end of the tunnel? | Pacher P et al. | β | 2004 | β |
| Candidate genes for alcohol dependence: a review of genetic evidence from human studies. | Dick DM et al. | β | 2003 | β |
| Neuroendocrine pharmacology of stress. | Carrasco GA et al. | β | 2003 | β |
| Neuropeptides: opportunities for drug discovery. | HΓΆkfelt T et al. | β | 2003 | β |
| Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. | Holmes A et al. | β | 2003 | β |
| Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence. | Pandey SC et al. | β | 2003 | β |
| NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations. | Zhu G et al. | β | 2003 | β |
| Pharmacogenomics of alcohol response and addiction. | Enoch MA | β | 2003 | β |
| Neuropeptide Y and its receptors as potential therapeutic drug targets. | Silva AP et al. | β | 2002 | β |